25 XP   0   0   10

Bionomics Ltd ADR
Buy, Hold or Sell?

Let's analyse Bionomics together

PenkeI guess you are interested in Bionomics Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bionomics Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bionomics Ltd ADR

I send you an email if I find something interesting about Bionomics Ltd ADR.

Quick analysis of Bionomics (30 sec.)










What can you expect buying and holding a share of Bionomics? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
$2.01
Expected worth in 1 year
$-3.76
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$-5.78
Return On Investment
-597.9%

For what price can you sell your share?

Current Price per Share
$0.97
Expected price per share
$0.87 - $1.25
How sure are you?
50%

1. Valuation of Bionomics (5 min.)




Live pricePrice per Share (EOD)

$0.97

Intrinsic Value Per Share

$-20.60 - $-6.31

Total Value Per Share

$-18.59 - $-4.29

2. Growth of Bionomics (5 min.)




Is Bionomics growing?

Current yearPrevious yearGrowGrow %
How rich?$21.5m$36.9m-$15.4m-71.7%

How much money is Bionomics making?

Current yearPrevious yearGrowGrow %
Making money-$20.6m-$14.1m-$6.5m-31.7%
Net Profit Margin-144,450.3%-8,253.6%--

How much money comes from the company's main activities?

3. Financial Health of Bionomics (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#576 / 1010

Most Revenue
#687 / 1010

Most Profit
#701 / 1010

Most Efficient
#998 / 1010

What can you expect buying and holding a share of Bionomics? (5 min.)

Welcome investor! Bionomics's management wants to use your money to grow the business. In return you get a share of Bionomics.

What can you expect buying and holding a share of Bionomics?

First you should know what it really means to hold a share of Bionomics. And how you can make/lose money.

Speculation

The Price per Share of Bionomics is $0.9663. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bionomics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bionomics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.01. Based on the TTM, the Book Value Change Per Share is $-1.44 per quarter. Based on the YOY, the Book Value Change Per Share is $0.57 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bionomics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.94-200.3%-1.94-200.3%-1.32-136.9%-0.97-100.4%-0.86-89.3%
Usd Book Value Change Per Share-1.44-149.5%-1.44-149.5%0.5758.6%0.2020.4%-0.05-5.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.022.0%0.011.0%
Usd Total Gains Per Share-1.44-149.5%-1.44-149.5%0.5758.6%0.2222.3%-0.04-4.2%
Usd Price Per Share2.20-2.20-6.99-1.84-0.92-
Price to Earnings Ratio-1.14--1.14--5.29--1.28--0.64-
Price-to-Total Gains Ratio-1.52--1.52-12.35-5.41-5.41-
Price to Book Ratio1.09-1.09-2.02-0.62-0.31-
Price-to-Total Gains Ratio-1.52--1.52-12.35-5.41-5.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.9663
Number of shares1034
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share-1.440.20
Usd Total Gains Per Share-1.440.22
Gains per Quarter (1034 shares)-1,493.44223.13
Gains per Year (1034 shares)-5,973.78892.53
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-5974-598479814883
20-11948-1195815716281776
30-17921-1793223624422669
40-23895-2390631432563562
50-29869-2988039340704455
60-35843-3585447248845348
70-41816-4182855056986241
80-47790-4780262965117134
90-53764-5377670773258027
100-59738-5975078681398920

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.09.00.010.0%1.024.00.04.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%5.05.00.050.0%14.011.00.056.0%
Dividend per Share0.00.01.00.0%1.00.02.033.3%3.00.02.060.0%3.00.07.030.0%5.00.020.020.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%5.05.00.050.0%14.011.00.056.0%

Fundamentals of Bionomics

About Bionomics Ltd ADR

Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. The company has a collaboration with Merck & Co., Inc. to identify novel a7 Nicotinic Acetylcholine Receptor PAMs suitable for the treatment of cognitive disorder. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.

Fundamental data was last updated by Penke on 2024-04-09 17:36:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Bionomics Ltd ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bionomics earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bionomics to the Biotechnology industry mean.
  • A Net Profit Margin of -144,450.3% means that $-1,444.50 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bionomics Ltd ADR:

  • The MRQ is -144,450.3%. The company is making a huge loss. -2
  • The TTM is -144,450.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-144,450.3%TTM-144,450.3%0.0%
TTM-144,450.3%YOY-8,253.6%-136,196.7%
TTM-144,450.3%5Y-33,642.3%-110,807.9%
5Y-33,642.3%10Y-16,948.2%-16,694.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-144,450.3%-207.2%-144,243.1%
TTM-144,450.3%-216.8%-144,233.5%
YOY-8,253.6%-282.3%-7,971.3%
5Y-33,642.3%-436.8%-33,205.5%
10Y-16,948.2%-597.3%-16,350.9%
1.1.2. Return on Assets

Shows how efficient Bionomics is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bionomics to the Biotechnology industry mean.
  • -74.1% Return on Assets means that Bionomics generated $-0.74 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bionomics Ltd ADR:

  • The MRQ is -74.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -74.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-74.1%TTM-74.1%0.0%
TTM-74.1%YOY-33.3%-40.7%
TTM-74.1%5Y-32.4%-41.6%
5Y-32.4%10Y-24.7%-7.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-74.1%-13.3%-60.8%
TTM-74.1%-12.8%-61.3%
YOY-33.3%-11.6%-21.7%
5Y-32.4%-13.8%-18.6%
10Y-24.7%-15.6%-9.1%
1.1.3. Return on Equity

Shows how efficient Bionomics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bionomics to the Biotechnology industry mean.
  • -96.1% Return on Equity means Bionomics generated $-0.96 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bionomics Ltd ADR:

  • The MRQ is -96.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -96.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-96.1%TTM-96.1%0.0%
TTM-96.1%YOY-38.2%-57.8%
TTM-96.1%5Y-52.7%-43.4%
5Y-52.7%10Y-51.3%-1.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-96.1%-16.9%-79.2%
TTM-96.1%-16.1%-80.0%
YOY-38.2%-14.9%-23.3%
5Y-52.7%-19.3%-33.4%
10Y-51.3%-20.1%-31.2%

1.2. Operating Efficiency of Bionomics Ltd ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bionomics is operating .

  • Measures how much profit Bionomics makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bionomics to the Biotechnology industry mean.
  • An Operating Margin of -142,889.2% means the company generated $-1,428.89  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bionomics Ltd ADR:

  • The MRQ is -142,889.2%. The company is operating very inefficient. -2
  • The TTM is -142,889.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-142,889.2%TTM-142,889.2%0.0%
TTM-142,889.2%YOY-8,095.4%-134,793.8%
TTM-142,889.2%5Y-34,020.6%-108,868.6%
5Y-34,020.6%10Y-17,132.1%-16,888.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-142,889.2%-298.0%-142,591.2%
TTM-142,889.2%-238.5%-142,650.7%
YOY-8,095.4%-288.4%-7,807.0%
5Y-34,020.6%-486.2%-33,534.4%
10Y-17,132.1%-628.4%-16,503.7%
1.2.2. Operating Ratio

Measures how efficient Bionomics is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1,451.29 means that the operating costs are $1,451.29 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bionomics Ltd ADR:

  • The MRQ is 1,451.291. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1,451.291. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1,451.291TTM1,451.2910.000
TTM1,451.291YOY82.945+1,368.345
TTM1,451.2915Y346.688+1,104.602
5Y346.68810Y175.711+170.978
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1,451.2913.235+1,448.056
TTM1,451.2913.310+1,447.981
YOY82.9453.838+79.107
5Y346.6885.679+341.009
10Y175.7117.823+167.888

1.3. Liquidity of Bionomics Ltd ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bionomics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.87 means the company has $4.87 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bionomics Ltd ADR:

  • The MRQ is 4.867. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.867. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.867TTM4.8670.000
TTM4.867YOY12.460-7.593
TTM4.8675Y6.651-1.785
5Y6.65110Y5.201+1.451
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8673.863+1.004
TTM4.8674.169+0.698
YOY12.4605.337+7.123
5Y6.6516.122+0.529
10Y5.2016.434-1.233
1.3.2. Quick Ratio

Measures if Bionomics is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bionomics to the Biotechnology industry mean.
  • A Quick Ratio of 4.58 means the company can pay off $4.58 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bionomics Ltd ADR:

  • The MRQ is 4.575. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.575. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.575TTM4.5750.000
TTM4.575YOY12.024-7.449
TTM4.5755Y6.202-1.626
5Y6.20210Y4.742+1.460
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5753.504+1.071
TTM4.5753.991+0.584
YOY12.0245.371+6.653
5Y6.2026.088+0.114
10Y4.7426.395-1.653

1.4. Solvency of Bionomics Ltd ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bionomics assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bionomics to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.23 means that Bionomics assets are financed with 22.9% credit (debt) and the remaining percentage (100% - 22.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bionomics Ltd ADR:

  • The MRQ is 0.229. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.229. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.229TTM0.2290.000
TTM0.229YOY0.129+0.101
TTM0.2295Y0.357-0.127
5Y0.35710Y0.441-0.084
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2290.339-0.110
TTM0.2290.337-0.108
YOY0.1290.271-0.142
5Y0.3570.368-0.011
10Y0.4410.388+0.053
1.4.2. Debt to Equity Ratio

Measures if Bionomics is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bionomics to the Biotechnology industry mean.
  • A Debt to Equity ratio of 29.7% means that company has $0.30 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bionomics Ltd ADR:

  • The MRQ is 0.297. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.297. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.297TTM0.2970.000
TTM0.297YOY0.148+0.150
TTM0.2975Y0.867-0.570
5Y0.86710Y1.094-0.227
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2970.392-0.095
TTM0.2970.403-0.106
YOY0.1480.335-0.187
5Y0.8670.427+0.440
10Y1.0940.461+0.633

2. Market Valuation of Bionomics Ltd ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bionomics generates.

  • Above 15 is considered overpriced but always compare Bionomics to the Biotechnology industry mean.
  • A PE ratio of -1.14 means the investor is paying $-1.14 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bionomics Ltd ADR:

  • The EOD is -0.499. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.137. Based on the earnings, the company is expensive. -2
  • The TTM is -1.137. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.499MRQ-1.137+0.637
MRQ-1.137TTM-1.1370.000
TTM-1.137YOY-5.286+4.149
TTM-1.1375Y-1.284+0.148
5Y-1.28410Y-0.642-0.642
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.499-2.300+1.801
MRQ-1.137-2.656+1.519
TTM-1.137-2.718+1.581
YOY-5.286-4.145-1.141
5Y-1.284-6.258+4.974
10Y-0.642-6.315+5.673
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bionomics Ltd ADR:

  • The EOD is -0.745. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.696. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.696. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.745MRQ-1.696+0.951
MRQ-1.696TTM-1.6960.000
TTM-1.696YOY-5.286+3.590
TTM-1.6965Y-1.396-0.300
5Y-1.39610Y-0.698-0.698
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.745-2.974+2.229
MRQ-1.696-3.306+1.610
TTM-1.696-3.508+1.812
YOY-5.286-5.613+0.327
5Y-1.396-8.378+6.982
10Y-0.698-8.873+8.175
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bionomics is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.09 means the investor is paying $1.09 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bionomics Ltd ADR:

  • The EOD is 0.480. Based on the equity, the company is cheap. +2
  • The MRQ is 1.092. Based on the equity, the company is underpriced. +1
  • The TTM is 1.092. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.480MRQ1.092-0.612
MRQ1.092TTM1.0920.000
TTM1.092YOY2.021-0.929
TTM1.0925Y0.623+0.469
5Y0.62310Y0.311+0.311
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.4801.914-1.434
MRQ1.0922.116-1.024
TTM1.0922.097-1.005
YOY2.0212.881-0.860
5Y0.6233.550-2.927
10Y0.3113.936-3.625
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bionomics Ltd ADR.

3.1. Institutions holding Bionomics Ltd ADR

Institutions are holding 21.667% of the shares of Bionomics Ltd ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30TANG CAPITAL MANAGEMENT LLC8.57880.26677000007000000
2023-09-30Point72 Asset Management, L.P.8.10850.0052661626535626425.1
2023-09-30Octagon Capital Advisors LP2.05890.06971680001680000
2023-12-31Morgan Stanley - Brokerage Accounts1.1639094967949670
2023-09-30Bvf Inc0.58060.003547372-33599-41.4951
2023-12-31Two Sigma Investments LLC0.38330.000131272312720
2023-12-31XTX Topco Ltd0.1450.003911834118340
2023-12-31Tower Research Capital LLC0.01970160615522874.0741
2023-12-31Rhumbline Advisers0.0062050500
2023-12-31UBS Group AG0.0040329-2152-86.7392
2023-12-31Aspire Private Capital, LLC0.00250.000120000
2023-09-30Woodline Partners LP000-54446-100
2023-12-31FNY Investment Advisers, LLC000-2120-100
2023-12-31Virtu Financial LLC000-16554-100
Total 21.05140.34921717711+1434380+83.5%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Bionomics Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.444-1.4440%0.566-355%0.197-834%-0.050-97%
Book Value Per Share--2.0152.0150%3.459-42%2.043-1%2.095-4%
Current Ratio--4.8674.8670%12.460-61%6.651-27%5.201-6%
Debt To Asset Ratio--0.2290.2290%0.129+78%0.357-36%0.441-48%
Debt To Equity Ratio--0.2970.2970%0.148+102%0.867-66%1.094-73%
Dividend Per Share----0%-0%0.019-100%0.010-100%
Eps---1.936-1.9360%-1.322-32%-0.970-50%-0.863-55%
Free Cash Flow Per Share---1.297-1.2970%-1.322+2%-0.854-34%-0.714-45%
Free Cash Flow To Equity Per Share---0.959-0.9590%0.318-401%-0.087-91%-0.047-95%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---6.309--------
Intrinsic Value_10Y_min---20.604--------
Intrinsic Value_1Y_max---0.698--------
Intrinsic Value_1Y_min---1.301--------
Intrinsic Value_3Y_max---2.047--------
Intrinsic Value_3Y_min---4.594--------
Intrinsic Value_5Y_max---3.335--------
Intrinsic Value_5Y_min---8.611--------
Market Cap10333032.420-128%23525480.00023525480.0000%74746866.000-69%19654469.200+20%9827234.600+139%
Net Profit Margin---1444.503-1444.5030%-82.536-94%-336.423-77%-169.482-88%
Operating Margin---1428.892-1428.8920%-80.954-94%-340.206-76%-171.321-88%
Operating Ratio--1451.2911451.2910%82.945+1650%346.688+319%175.711+726%
Pb Ratio0.480-128%1.0921.0920%2.021-46%0.623+75%0.311+251%
Pe Ratio-0.499+56%-1.137-1.1370%-5.286+365%-1.284+13%-0.642-43%
Price Per Share0.966-128%2.2002.2000%6.990-69%1.838+20%0.919+139%
Price To Free Cash Flow Ratio-0.745+56%-1.696-1.6960%-5.286+212%-1.396-18%-0.698-59%
Price To Total Gains Ratio-0.669+56%-1.523-1.5230%12.347-112%5.412-128%5.412-128%
Quick Ratio--4.5754.5750%12.024-62%6.202-26%4.742-4%
Return On Assets---0.741-0.7410%-0.333-55%-0.324-56%-0.247-67%
Return On Equity---0.961-0.9610%-0.382-60%-0.527-45%-0.513-47%
Total Gains Per Share---1.444-1.4440%0.566-355%0.216-769%-0.041-97%
Usd Book Value--21542793.56421542793.5640%36987663.815-42%21841630.972-1%22399928.087-4%
Usd Book Value Change Per Share---1.444-1.4440%0.566-355%0.197-834%-0.050-97%
Usd Book Value Per Share--2.0152.0150%3.459-42%2.043-1%2.095-4%
Usd Dividend Per Share----0%-0%0.019-100%0.010-100%
Usd Eps---1.936-1.9360%-1.322-32%-0.970-50%-0.863-55%
Usd Free Cash Flow---13871054.863-13871054.8630%-14139894.447+2%-9128796.824-34%-7633476.618-45%
Usd Free Cash Flow Per Share---1.297-1.2970%-1.322+2%-0.854-34%-0.714-45%
Usd Free Cash Flow To Equity Per Share---0.959-0.9590%0.318-401%-0.087-91%-0.047-95%
Usd Market Cap10333032.420-128%23525480.00023525480.0000%74746866.000-69%19654469.200+20%9827234.600+139%
Usd Price Per Share0.966-128%2.2002.2000%6.990-69%1.838+20%0.919+139%
Usd Profit---20697337.354-20697337.3540%-14141406.764-32%-10280216.335-50%-9181623.425-56%
Usd Revenue--14328.34514328.3450%171335.737-92%540296.835-97%2992154.418-100%
Usd Total Gains Per Share---1.444-1.4440%0.566-355%0.216-769%-0.041-97%
 EOD+3 -5MRQTTM+0 -0YOY+5 -285Y+6 -2910Y+7 -28

4.2. Fundamental Score

Let's check the fundamental score of Bionomics Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.499
Price to Book Ratio (EOD)Between0-10.480
Net Profit Margin (MRQ)Greater than0-1,444.503
Operating Margin (MRQ)Greater than0-1,428.892
Quick Ratio (MRQ)Greater than14.575
Current Ratio (MRQ)Greater than14.867
Debt to Asset Ratio (MRQ)Less than10.229
Debt to Equity Ratio (MRQ)Less than10.297
Return on Equity (MRQ)Greater than0.15-0.961
Return on Assets (MRQ)Greater than0.05-0.741
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Bionomics Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.878
Ma 20Greater thanMa 500.986
Ma 50Greater thanMa 1001.073
Ma 100Greater thanMa 2001.116
OpenGreater thanClose0.940
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Net Interest Income  -1,353191-1,162227-935912-22315293



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets43,004
Total Liabilities9,856
Total Stockholder Equity33,148
 As reported
Total Liabilities 9,856
Total Stockholder Equity+ 33,148
Total Assets = 43,004

Assets

Total Assets43,004
Total Current Assets20,096
Long-term Assets22,908
Total Current Assets
Cash And Cash Equivalents 18,250
Net Receivables 643
Total Current Assets  (as reported)20,096
Total Current Assets  (calculated)18,893
+/- 1,203
Long-term Assets
Property Plant Equipment 502
Goodwill 13,084
Intangible Assets 9,203
Other Assets 119
Long-term Assets  (as reported)22,908
Long-term Assets  (calculated)22,908
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,129
Long-term Liabilities5,727
Total Stockholder Equity33,148
Total Current Liabilities
Short-term Debt 172
Accounts payable 2,063
Other Current Liabilities 1,895
Total Current Liabilities  (as reported)4,129
Total Current Liabilities  (calculated)4,129
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt362
Other Liabilities 5,365
Long-term Liabilities  (as reported)5,727
Long-term Liabilities  (calculated)5,727
+/-0
Total Stockholder Equity
Common Stock223,413
Retained Earnings -204,771
Other Stockholders Equity 14,506
Total Stockholder Equity (as reported)33,148
Total Stockholder Equity (calculated)33,148
+/-0
Other
Capital Stock223,413
Cash and Short Term Investments 18,250
Common Stock Shares Outstanding 8,160
Liabilities and Stockholders Equity 43,004
Net Debt -17,717
Net Invested Capital 33,148
Net Tangible Assets 10,861
Net Working Capital 15,966
Property Plant and Equipment Gross 927
Short Long Term Debt Total 534



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-30
> Total Assets 
213
5,308
10,829
15,839
12,571
14,962
17,050
19,715
30,821
28,313
24,725
31,514
34,309
31,102
53,611
65,061
69,132
88,010
84,075
65,066
53,659
34,463
54,263
65,310
43,004
43,00465,31054,26334,46353,65965,06684,07588,01069,13265,06153,61131,10234,30931,51424,72528,31330,82119,71517,05014,96212,57115,83910,8295,308213
   > Total Current Assets 
213
4,688
9,964
8,833
6,203
8,971
9,438
5,158
13,955
8,856
5,888
13,896
24,886
21,738
30,715
39,518
37,881
58,086
54,478
35,920
25,132
8,333
30,927
41,810
20,096
20,09641,81030,9278,33325,13235,92054,47858,08637,88139,51830,71521,73824,88613,8965,8888,85613,9555,1589,4388,9716,2038,8339,9644,688213
       Cash And Cash Equivalents 
86
523
1
8,592
6,070
8,703
9,005
4,728
12,821
6,280
4,757
12,612
16,052
17,337
22,452
10,500
26,558
45,450
42,874
24,930
13,985
4,578
28,499
33,565
18,250
18,25033,56528,4994,57813,98524,93042,87445,45026,55810,50022,45217,33716,05212,6124,7576,28012,8214,7289,0058,7036,0708,592152386
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
26
0
36
0
0
550
550
550
550
550
0
327
0
0
003270550550550550550003602600000000000
       Net Receivables 
0
73
85
99
27
135
141
242
339
2,315
775
847
8,449
411
706
20,740
1,064
11,003
9,893
713
887
59
1,131
6,784
643
6436,7841,131598877139,89311,0031,06420,7407064118,4498477752,315339242141135279985730
       Other Current Assets 
127
78
26
68
34
56
9
35
593
38
7
26
96
3,109
7,000
7,515
8,105
0
3
8,284
7,838
2,921
699
1,461
0
01,4616992,9217,8388,284308,1057,5157,0003,10996267385933595634682678127
   > Long-term Assets 
0
620
866
7,006
6,367
5,991
7,611
14,557
16,866
19,457
18,837
17,618
9,423
9,364
22,896
25,543
31,251
29,924
29,597
29,146
28,527
26,130
23,336
23,500
22,908
22,90823,50023,33626,13028,52729,14629,59729,92431,25125,54322,8969,3649,42317,61818,83719,45716,86614,5577,6115,9916,3677,0068666200
       Property Plant Equipment 
0
435
724
6,906
6,311
5,977
5,654
5,646
8,628
8,618
8,379
7,908
303
773
843
828
3,451
2,835
2,618
2,744
2,507
1,055
871
675
502
5026758711,0552,5072,7442,6182,8353,4518288437733037,9088,3798,6188,6285,6465,6545,9776,3116,9067244350
       Goodwill 
0
0
0
0
0
0
1,956
2,177
2,127
5,148
5,148
5,148
5,148
5,148
5,148
9,488
10,489
10,642
12,264
12,470
12,761
12,872
12,401
12,868
13,084
13,08412,86812,40112,87212,76112,47012,26410,64210,4899,4885,1485,1485,1485,1485,1485,1482,1272,1771,956000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
384
384
436
119
0
0
001194363843840000000000000000000
       Intangible Assets 
0
184
142
99
57
14
1
6,734
6,110
5,691
5,310
4,563
3,972
3,372
16,905
15,226
16,928
16,063
14,331
13,548
12,874
11,766
9,946
9,838
9,203
9,2039,8389,94611,76612,87413,54814,33116,06316,92815,22616,9053,3723,9724,5635,3105,6916,1106,73411457991421840
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
384
384
436
119
119
119
1191191194363843840000000000000000000
> Total Liabilities 
758
246
642
5,850
5,856
6,031
6,371
8,768
8,122
6,786
6,030
6,049
5,610
5,203
12,204
20,242
37,166
45,577
43,621
48,108
35,961
21,781
6,666
8,397
9,856
9,8568,3976,66621,78135,96148,10843,62145,57737,16620,24212,2045,2035,6106,0496,0306,7868,1228,7686,3716,0315,8565,850642246758
   > Total Current Liabilities 
708
174
592
843
1,230
1,405
2,035
2,681
3,613
3,051
2,791
3,236
5,480
4,468
6,083
9,281
13,706
11,386
13,889
13,285
13,802
8,272
2,361
3,356
4,129
4,1293,3562,3618,27213,80213,28513,88911,38613,7069,2816,0834,4685,4803,2362,7913,0513,6132,6812,0351,4051,230843592174708
       Short-term Debt 
200
0
22
127
508
508
358
414
542
572
529
627
2,828
733
680
789
5,460
3,874
8,496
5,834
8,452
5,953
174
160
172
1721601745,9538,4525,8348,4963,8745,4607896807332,828627529572542414358508508127220200
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,834
8,452
5,185
0
0
0
0005,1858,4525,8340000000000000000000
       Accounts payable 
508
151
154
345
350
524
958
1,077
2,120
1,725
1,137
1,384
1,357
1,991
3,272
2,663
3,933
2,633
1,900
3,607
1,203
1,261
1,029
1,557
2,063
2,0631,5571,0291,2611,2033,6071,9002,6333,9332,6633,2721,9911,3571,3841,1371,7252,1201,077958524350345154151508
       Other Current Liabilities 
0
22
366
248
351
323
563
1,945
1,683
1,026
2,042
1,154
1,247
1,726
2,092
2,561
4,237
4,813
3,473
3,756
3,922
1,058
1,158
1,639
1,895
1,8951,6391,1581,0583,9223,7563,4734,8134,2372,5612,0921,7261,2471,1542,0421,0261,6831,945563323351248366220
   > Long-term Liabilities 
50
72
50
5,007
4,626
4,626
4,335
6,087
4,509
3,735
3,239
2,813
130
735
6,122
10,961
23,460
34,191
29,733
34,823
22,159
13,509
4,305
5,042
5,727
5,7275,0424,30513,50922,15934,82329,73334,19123,46010,9616,1227351302,8133,2393,7354,5096,0874,3354,6264,6265,007507250
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,087
13,511
7,224
3,612
4,508
5,365
5,3654,5083,6127,22413,51119,0870000000000000000000
> Total Stockholder Equity
-545
5,062
10,187
9,989
6,715
8,931
10,679
10,946
22,699
21,527
18,695
25,466
28,699
25,899
41,407
44,819
31,966
42,433
40,454
16,958
17,698
12,682
47,598
56,913
33,148
33,14856,91347,59812,68217,69816,95840,45442,43331,96644,81941,40725,89928,69925,46618,69521,52722,69910,94610,6798,9316,7159,98910,1875,062-545
   Common Stock
376
7,402
15,806
19,098
20,365
26,155
32,792
38,038
52,834
56,099
59,970
75,114
87,691
87,835
111,313
111,722
111,990
134,393
134,536
135,212
144,944
148,156
190,190
217,696
223,413
223,413217,696190,190148,156144,944135,212134,536134,393111,990111,722111,31387,83587,69175,11459,97056,09952,83438,03832,79226,15520,36519,09815,8067,402376
   Retained Earnings -204,771-173,307-154,041-148,888-140,866-131,353-108,196-103,176-86,567-69,618-72,824-62,823-59,687-52,836-44,622-37,759-32,975-27,526-21,857-17,224-13,650-9,109-5,619-2,340-921
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,098
13,620
13,414
11,448
12,524
14,506
14,50612,52411,44813,41413,62013,0980000000000000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue22
Cost of Revenue--
Gross Profit2222
 
Operating Income (+$)
Gross Profit22
Operating Expense-31,997
Operating Income-31,503-31,975
 
Operating Expense (+$)
Research Development19,613
Selling General Administrative8,857
Selling And Marketing Expenses-
Operating Expense31,99728,470
 
Net Interest Income (+$)
Interest Income480
Interest Expense-21
Other Finance Cost-8
Net Interest Income450
 
Pretax Income (+$)
Operating Income-31,503
Net Interest Income450
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-32,054-30,973
EBIT - interestExpense = -31,524
-32,054
-31,826
Interest Expense21
Earnings Before Interest and Taxes (EBIT)-31,503-32,032
Earnings Before Interest and Taxes (EBITDA)-30,346
 
After tax Income (+$)
Income Before Tax-32,054
Tax Provision--207
Net Income From Continuing Ops-31,847-31,847
Net Income-31,847
Net Income Applicable To Common Shares-31,847
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses31,997
Total Other Income/Expenses Net-530-450
 

Technical Analysis of Bionomics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bionomics. The general trend of Bionomics is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bionomics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bionomics Ltd ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.05 < 1.05 < 1.25.

The bearish price targets are: 0.9062 > 0.89 > 0.87.

Tweet this
Bionomics Ltd ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bionomics Ltd ADR. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bionomics Ltd ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bionomics Ltd ADR. The current macd is -0.02778232.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bionomics price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bionomics. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bionomics price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bionomics Ltd ADR Daily Moving Average Convergence/Divergence (MACD) ChartBionomics Ltd ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bionomics Ltd ADR. The current adx is 10.05.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bionomics shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Bionomics Ltd ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bionomics Ltd ADR. The current sar is 1.0472.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bionomics Ltd ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bionomics Ltd ADR. The current rsi is 43.88. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Bionomics Ltd ADR Daily Relative Strength Index (RSI) ChartBionomics Ltd ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bionomics Ltd ADR. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bionomics price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Bionomics Ltd ADR Daily Stochastic Oscillator ChartBionomics Ltd ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bionomics Ltd ADR. The current cci is -72.25639654.

Bionomics Ltd ADR Daily Commodity Channel Index (CCI) ChartBionomics Ltd ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bionomics Ltd ADR. The current cmo is -9.1624234.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bionomics Ltd ADR Daily Chande Momentum Oscillator (CMO) ChartBionomics Ltd ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bionomics Ltd ADR. The current willr is -59.78571429.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Bionomics is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Bionomics Ltd ADR Daily Williams %R ChartBionomics Ltd ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bionomics Ltd ADR.

Bionomics Ltd ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bionomics Ltd ADR. The current atr is 0.06394939.

Bionomics Ltd ADR Daily Average True Range (ATR) ChartBionomics Ltd ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bionomics Ltd ADR. The current obv is 193,625,699.

Bionomics Ltd ADR Daily On-Balance Volume (OBV) ChartBionomics Ltd ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bionomics Ltd ADR. The current mfi is 44.60.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Bionomics Ltd ADR Daily Money Flow Index (MFI) ChartBionomics Ltd ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bionomics Ltd ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Bionomics Ltd ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bionomics Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.878
Ma 20Greater thanMa 500.986
Ma 50Greater thanMa 1001.073
Ma 100Greater thanMa 2001.116
OpenGreater thanClose0.940
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bionomics with someone you think should read this too:
  • Are you bullish or bearish on Bionomics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bionomics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bionomics Ltd ADR

I send you an email if I find something interesting about Bionomics Ltd ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Bionomics Ltd ADR.

Receive notifications about Bionomics Ltd ADR in your mailbox!